- Endotoxin-free ClearColi™ Expression System
- Fibronectin Artificial Antibody Scaffold
- Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)
- Pichia Classic Expression Platform
- Pichia GlyoSwitch™ Protein Expression System
- Ultrasound Tissue Harmonic Imaging
- VIMPAT® (lacosamide) for Treatment of Epileptic Seizures
The RCT Ventures program is the vehicle through which Research Corporation Technologies invests in start-up or early-stage companies with technologies that promise patented biomedical and life science products with a clear competitive advantage
RCT has two primary areas of interest for venture investing:
- Biotechnology Therapeutics and Tools
